JSPRW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 09:30):
Our systems believe the stock currently is overvalued by -0.07% compare to its pairs and should correct downwards.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies...

Stats
Today's Volume	220
Average Volume	0
Market Cap	322.78M
EPS	$-1.030 ( Q1 \| 2024-05-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -3.53%

ABCL 1.87%

ABCM 0.04%

ABEO -2.13%

ABIO -2.23%

ABOS 0.00%

ABSI 1.87%

ABUS -2.13%

ABVX -2.03%

ACAD -0.58%

ACER -17.95%

ACET -5.10%

ACGN 1.29%

ACHL -2.22%

ACHV -1.29%

ACIU -1.50%

ACLX 0.25%

ACRV -5.61%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -3.93%

ADGI 0.87%

ADIL 0.54%

ADMA -2.81%

ADPT -0.15%

ADTX -3.47%

ADVM -3.40%

ADXN -1.60%

AEON -3.74%

AEZS -2.51%

AFMD -0.61%

AGEN -3.03%

AGIO -2.48%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -2.12%

AKRO -2.59%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -1.15%

ALGS -2.30%

ALKS -0.21%

ALLK -8.86%

ALLO -4.61%

ALLR -3.37%

ALNA 3.16%

ALNY 2.42%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.58%

ALVR -0.40%

ALXN 0.00%

ALXO -11.18%

ALZN 2.04%

AMRN -0.72%

AMTI -3.13%

ANAB 1.05%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.75%

ANPC -3.15%

APGE -1.05%

APGN 8.48%

APGNW 30.65%

APLM -6.42%

APLS 0.50%

APLT -3.72%

APM -2.94%

APOP 0.38%

APRE 0.61%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.38%

ARDS -14.23%

ARDX -0.50%

ARGX -1.09%

ARNA 0.00%

ARPO -0.90%

ARQT -1.30%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.68%

ARWR -1.71%

ASLN -5.07%

ASMB -5.83%

ASND -1.45%

ATAI -1.48%

ATHA 5.48%

ATHE 0.55%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -2.83%

ATXI 1.93%

ATXS -0.67%

AUPH -0.90%

AURA 1.17%

AUTL -2.01%

AVBP -4.23%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.14%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -1.57%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.84%

BCAB 3.92%

BCDA -2.73%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 0.99%

BCTX 8.16%

BCTXW -17.41%

BCYC 1.35%

BDRX -4.94%

BDTX -0.85%

BEAM 0.79%

BFRA -2.91%

BGNE -2.99%

BIOR -3.80%

BIVI 3.85%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.44%

BMEA -11.51%

BMRN 0.48%

BNOX 4.61%

BNTC -0.42%

BNTX -1.87%

BOLD -8.58%

BOLT 0.72%

BPMC -0.99%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 25.46%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.18%

CADL -1.31%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA 0.39%

CARM 10.43%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.39%

CCCC -5.20%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -12.20%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.00%

CDXS 7.24%

CELC -4.67%

CELU -1.97%

CELUW 11.80%

CERC -1.68%

CERE -1.01%

CERO -4.45%

CEROW -20.21%

CFRX -27.95%

CGEM -2.19%

CGEN -3.87%

CGON -0.83%

CGTX -4.54%

CHMA -6.00%

CHRS 0.34%

CINC 0.00%

CING 2.15%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.21%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.46%

CMPI 0.00%

CMPX -6.08%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -36.93%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.40%

CORT 2.02%

COYA -1.46%

CPRX -1.12%

CRBP -3.45%

CRBU -4.81%

CRDF -0.89%

CRGX 0.47%

CRIS -0.38%

CRNX -5.88%

CRSP 1.21%

CRTX 2.63%

CRVO -2.50%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -2.89%

CTNM -1.35%

CTXR 2.01%

CUE 3.78%

CVAC -2.54%

CVKD 0.11%

CWBR 2.80%

CYAD -12.96%

CYCC 10.09%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.76%

CYTO -1.82%

DARE 6.41%

DAWN 0.41%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 26.55%

DNLI -1.56%

DNTH -8.81%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.96%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 6.82%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.56%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.40%

ELYM 2.30%

ENGN -3.64%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 5.21%

ENTA -0.57%

ENTO -2.47%

ENTX 2.08%

ENVB 1.45%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.12%

EXAI -0.66%

EXEL -0.25%

EYEG -0.69%

EYEN 0.43%

EYPT 0.10%

FATE -7.66%

FBIO 0.89%

FBIOP 0.92%

FBLG -15.40%

FBRX -0.04%

FDMT -3.79%

FENC -1.29%

FGEN -5.56%

FHTX 1.71%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.53%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.09%

FULC -3.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.20%

GHRS -2.16%

GLMD -2.33%

GLPG -2.26%

GLSI 1.69%

GLTO -0.57%

GLUE -2.50%

GLYC -9.53%

GMAB -0.58%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.91%

GNLX 1.10%

GNPX 0.98%

GNTA 3.94%

GOSS -11.98%

GOVX 5.00%

GOVXW -49.04%

GPCR -6.93%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.36%

GRTX 2.57%

GTHX 1.14%

GUTS -5.54%

GXGXW 41.67%

GYRE -4.95%

HALO -1.49%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -0.46%

HOOK -0.76%

HOTH -2.70%

HOWL -2.56%

HRMY 0.37%

HRTX 3.11%

HSTO 0.00%

HUMA 0.61%

HUMAW -0.01%

IBRX -4.06%

ICCC 0.22%

ICPT 0.21%

ICU 17.27%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.72%

IFRX -1.85%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB -0.29%

IMCR -2.99%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.99%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.81%

INAB -0.01%

INBX 0.43%

INCY -0.94%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 3.36%

INMB 2.44%

INO -1.95%

INSM -1.23%

INTS -2.75%

INVA 0.34%

INZY 1.03%

IOBT -11.81%

IONS 0.23%

IOVA -2.07%

IPA 2.50%

IPHA 5.58%

IPSC -1.95%

IRON -2.43%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.07%

JAGX 1.45%

JANX -4.05%

JAZZ -0.69%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.99%

KDNY 0.22%

KMPH -0.34%

KNSA -2.87%

KNTE -0.38%

KOD -6.92%

KPRX 0.96%

KPTI -2.29%

KRBP -10.00%

KRON 1.05%

KROS -1.38%

KRRO -8.23%

KRTX 0.03%

KRYS -1.16%

KTRA 16.18%

KTTA 8.16%

KTTAW 0.92%

KURA -1.51%

KYMR -2.60%

KYTX -4.13%

KZIA 2.65%

KZR -0.93%

LABP 0.57%

LBPH -2.11%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -3.73%

LEXX 1.16%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.80%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.48%

LPCN -2.95%

LPTX -1.65%

LQDA -0.90%

LRMR -2.20%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.01%

LXEO -4.21%

LXRX -2.06%

LYEL -33.43%

LYRA 0.93%

MACK 0.10%

MBIO -11.00%

MBRX -2.57%

MCRB 2.43%

MDGL -3.53%

MDNA -13.16%

MDWD 0.03%

MDXG -2.58%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.56%

MGX -2.68%

MIRM -1.89%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.89%

MLYS -6.49%

MNKD -0.95%

MNMD 0.50%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.20%

MORF -2.77%

MREO -4.14%

MRKR 2.68%

MRNA -5.17%

MRNS -4.04%

MRSN -1.90%

MRTX -0.17%

MRUS 0.25%

MRVI -1.81%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 1.72%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.93%

NKGN 9.80%

NKGNW 8.00%

NKTR -4.22%

NKTX -4.89%

NLSP 5.94%

NLSPW 26.67%

NMRA -3.31%

NMTR -42.97%

NOVN -24.84%

NRBO 12.63%

NRIX -0.31%

NRSN -5.18%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.60%

NTRBW -31.07%

NUVL -1.53%

NVAX -2.39%

NVCT 2.38%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -3.36%

OBSV 0.00%

OCEA -0.70%

OCGN 3.39%

OCS -1.00%

OCUL -1.83%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.88%

OMER -0.51%

OMGA 4.98%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.67%

ORIC -3.42%

ORMP 21.43%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.29%

OVID -1.43%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -4.89%

PBYI 1.35%

PCSA 0.00%

PCVX -0.46%

PDSB -3.52%

PEPG 2.56%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.19%

PLUR 7.49%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -10.64%

PRAX 0.92%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR -0.60%

PRTA -2.26%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -6.18%

PSTX -0.58%

PTCT -0.64%

PTE -0.82%

PTGX -1.39%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.63%

QLGN -6.52%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -1.83%

QURE -0.84%

RAIN -1.63%

RANI 6.42%

RAPT -3.57%

RARE 1.33%

RCKT -7.81%

REGN -0.26%

RENB -3.42%

REPL -2.83%

RETA 0.02%

REUN -0.89%

REVB -2.78%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.93%

RIGL -3.28%

RLAY -3.78%

RLMD 0.33%

RLYB -0.34%

RNA 0.00%

RNAC -5.94%

RNAZ -0.96%

RNXT 1.88%

ROIV -1.99%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.24%

RPTX -2.49%

RUBY 2.70%

RVLP -32.05%

RVMD -0.93%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.52%

RYTM -6.34%

RYZB 0.02%

RZLT 0.78%

SABS -1.37%

SABSW -11.81%

SAGE 1.83%

SANA -3.78%

SAVA -0.47%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -4.74%

SEER 0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.13%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -6.38%

SLGL 2.97%

SLN -4.40%

SLNO -4.14%

SLRX 6.07%

SLS -2.14%

SMMT -2.62%

SNDX 1.43%

SNGX -3.40%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.23%

SRRA 0.00%

SRRK -2.35%

SRZN -2.45%

STAB 0.00%

STOK -4.86%

STRO -3.01%

STSA 0.00%

STTK -1.83%

SURF -0.93%

SVRA -4.87%

SWTX 0.18%

SYBX -1.30%

SYRS -1.03%

TALS -0.73%

TARA -8.10%

TARS -0.56%

TBPH 0.24%

TCBP 2.47%

TCDA 0.00%

TCON 2.74%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.07%

TENX -1.27%

TERN -7.45%

TFFP -5.33%

TGTX -3.23%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -3.10%

TNGX -2.60%

TNXP -6.11%

TNYA -5.45%

TPST 2.98%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -24.90%

TSVT -2.93%

TTNP -7.79%

TVTX 0.88%

TYRA -7.43%

UBX -0.71%

UNCY -3.90%

URGN -1.52%

UTHR -0.48%

VACC 11.36%

VALN -2.89%

VAXX 83.69%

VBIV 0.78%

VBLT -8.77%

VCEL -0.23%

VCNX 10.35%

VCYT -1.06%

VERA -3.78%

VERU -0.73%

VERV -2.87%

VIGL 7.53%

VINC 2.96%

VIR 0.65%

VIRI -1.61%

VIRX 2.40%

VKTX -1.36%

VLON -13.04%

VNDA -2.61%

VOR -2.02%

VRCA 0.00%

VRDN -4.24%

VRNA -1.40%

VRPX 0.38%

VRTX 0.39%

VSTM -2.10%

VTGN -1.05%

VTVT -2.97%

VTYX -1.26%

VXRT -3.72%

VYGR -0.77%

VYNE -4.34%

VYNT 7.78%

WINT -3.24%

WVE -4.19%

XBIO 0.93%

XBIT -2.71%

XCUR 3.58%

XENE -2.81%

XERS 2.14%

XFOR 2.86%

XLO 4.54%

XLRN 0.00%

XNCR 0.36%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.96%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.89%

ZNTL -0.69%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-11-28	Wiggans Thomas G	Buy	10 000	Voting Common Stock
2023-11-21	Wiggans Thomas G	Buy	10 000	Voting Common Stock
2023-11-20	Wiggans Thomas G	Buy	10 000	Voting Common Stock
2023-11-17	Wiggans Thomas G	Buy	10 000	Voting Common Stock
2023-11-16	Wiggans Thomas G	Buy	10 000	Voting Common Stock

INSIDER POWER
90.52
Last 82 transactions
Buy: 29 502 185 \| Sell: 1 800 772

Correlation (AI algo v.1.1b): Overvalued: -0.07% $0.200 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Jasper Therapeutics, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jasper Therapeutics, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2023
Revenue:	$0
Gross Profit:	$-1.11M (0.00 %)
EPS:	$-6.18

FY	2022
Revenue:	$0
Gross Profit:	$-1.31M (0.00 %)
EPS:	$-6.63

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Jasper Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company\'s lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.